TherapeuticsMD, Inc. Announces Oral Presentation Of Positive Phase 2 And Bioavailability Data On TX-004HR (VagiCaptm)
TherapeuticsMD Inc. (NYSE MKT:TXMD), an innovative women’s healthcare company, announced today that positive results from phase 2 and pharmacokinetic studies of TX-004HR will be presented at the 25th Annual Meeting of The North American Menopause Society, October 15-18, 2014, at the Gaylord National Resort & Convention Center in Washington, D.C.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.